Jane Street’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Jane Street’s Portfolio FXH Stock Details FXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,606	Closed	-$1.79M	–	12092
2026 Q1	$1.71M	Buy	+15,606	New	+$1.77M	﹤0.01%	5388
2025 Q3	–	Sell	-5,759	Closed	-$597K	–	11089
2025 Q2	$597K	Sell	5,759 -4,586	-44%	-$461K	﹤0.01%	6584
2025 Q1	$1.07M	Sell	10,345 -10,780	-51%	-$1.15M	﹤0.01%	5441
2024 Q4	$2.2M	Sell	21,125 -10,107	-32%	-$1.1M	﹤0.01%	3937
2024 Q3	$3.49M	Buy	31,232 +9,470	+44%	+$1.04M	﹤0.01%	3457
2024 Q2	$2.27M	Buy	21,762 +14,742	+210%	+$1.55M	﹤0.01%	4263
2024 Q1	$769K	Buy	+7,020	New	+$742K	﹤0.01%	5892
2023 Q4	–	Sell	-20,701	Closed	-$2.01M	–	9379
2023 Q3	$2.01M	Sell	20,701 -33,847	-62%	-$3.51M	﹤0.01%	4047
2023 Q2	$5.91M	Buy	54,548 +42,648	+358%	+$4.57M	﹤0.01%	2515
2023 Q1	$1.28M	Buy	+11,900	New	+$1.29M	﹤0.01%	4566
2022 Q4	–	Sell	-139,637	Closed	-$13.6M	–	9458
2022 Q3	$13.6M	Buy	+139,637	New	+$14.7M	0.01%	1415
2020 Q3	–	Sell	-36,795	Closed	-$3.32M	–	7396
2020 Q2	$3.32M	Buy	36,795 +31,413	+584%	+$2.69M	﹤0.01%	2361
2020 Q1	$398K	Sell	5,382 -3,287	-38%	-$267K	﹤0.01%	3897
2019 Q4	$730K	Buy	+8,669	New	+$686K	﹤0.01%	3202
2019 Q3	–	Sell	-9,511	Closed	-$737K	–	5299
2019 Q2	$737K	Sell	9,511 -12,376	-57%	-$920K	﹤0.01%	3095
2019 Q1	$1.67M	Sell	21,887 -56,368	-72%	-$4.2M	﹤0.01%	2216
2018 Q4	$5.39M	Buy	78,255 +10,460	+15%	+$792K	0.01%	899
2018 Q3	$5.75M	Sell	67,795 -1,543	-2%	-$123K	0.01%	936
2018 Q2	$5.15M	Buy	69,338 +51,893	+297%	+$3.75M	0.01%	1015
2018 Q1	$1.21M	Buy	17,445 +2,111	+14%	+$152K	﹤0.01%	2420
2017 Q4	$1.07M	Buy	15,334 +11,684	+320%	+$798K	﹤0.01%	2266
2017 Q3	$246K	Buy	+3,650	New	+$244K	﹤0.01%	3912
2017 Q1	–	Sell	-35,951	Closed	-$2.06M	–	4327
2016 Q4	$2.06M	Buy	35,951 +1,463	+4%	+$84.7K	0.01%	1295
2016 Q3	$2.1M	Sell	34,488 -786	-2%	-$47.8K	0.01%	1172
2016 Q2	$2.08M	Sell	35,274 -35,070	-50%	-$2.03M	0.01%	1250
2016 Q1	$3.92M	Buy	+70,344	New	+$3.8M	0.02%	692
2015 Q4	–	Sell	-187,558	Closed	-$10.9M	–	4146
2015 Q3	$10.9M	Buy	187,558 +173,939	+1,277%	+$11.5M	0.07%	237
2015 Q2	$938K	Sell	13,619 -639	-4%	-$43.2K	0.01%	1628
2015 Q1	$956K	Sell	14,258 -36,572	-72%	-$2.33M	0.01%	1412
2014 Q4	$3.06M	Buy	50,830 +22,521	+80%	+$1.31M	0.02%	491
2014 Q3	$1.58M	Buy	28,309 +7,498	+36%	+$411K	0.02%	691
2014 Q2	$1.11M	Buy	+20,811	New	+$1.06M	0.01%	844

Other funds holding FXH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PWP

Prasad Wealth Partners Independence, Ohio $416M AUM 21.9% 1-Year Est. Return

PFA

Perryman Financial Advisory Dallas, Texas $751M AUM

Jane Street's FXH Position: Q2 2026 in Review

Jane Street sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q2 2026, closing a stake of 15,606 shares — an estimated $1.79M sold.

Jane Street first reported a position in FXH in Q2 2014 and held it in 32 quarters. The position peaked at $13.6M in Q3 2022. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

Jane Street reported no remaining First Trust Health Care AlphaDEX Fund position as of Q2 2026 after selling out during the quarter.
Jane Street sold 15,606 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $1.79M.
Jane Street first reported a position in First Trust Health Care AlphaDEX Fund in Q2 2014 and held it in 32 quarters.
Jane Street's First Trust Health Care AlphaDEX Fund position peaked at $13.6M in Q3 2022.
252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.